Last updated: February 27, 2026
What is the excipient profile for GOOD SENSE ALL DAY ALLERGY?
The formulation of GOOD SENSE ALL DAY ALLERGY primarily focuses on delivering antihistamine agents with user-friendly dosage forms. The product is available as a dissolvable tablet or liquid, optimized for quick onset and sustained relief. Typical excipients include:
- Binder: Microcrystalline cellulose
- Disintegrant: Croscarmellose sodium
- Fillers: Dextrose or lactose monohydrate
- Sweeteners: Aspartame or sucralose (for chewable forms)
- Flavoring agents: Fruit flavors (e.g., cherry, berry)
- Preservatives: Sodium benzoate (for liquids)
- Stabilizers and antioxidants: Ascorbic acid
No proprietary excipient complex is publicly reported, but the selection supports rapid dissolution, stability, and palatability.
How does excipient choice influence product performance?
Excipient selection affects onset and duration of action, stability, patient compliance, and manufacturing efficiency:
- Dissolution: Croscarmellose sodium promotes rapid disintegration, enabling quick antihistamine release.
- Taste masking: Sweeteners and flavors improve acceptability, especially in pediatric formulations.
- Shelf life: Antioxidants and preservatives prevent oxidation and microbial growth, extending shelf stability.
- Manufacturability: Microcrystalline cellulose provides compressibility and flow properties, reducing production costs.
Optimizing these excipients aligns with consumer preferences and regulatory standards, including tolerability and safety.
What are the commercial opportunities stemming from excipient strategies?
Aligning excipient strategies with market demands offers multiple opportunities:
1. Development of Pediatric-Friendly Formulations
Incorporating excipients such as fruit flavors, sweeteners, and disintegrants supports the creation of chewables and liquids. This expands access to younger demographics and increases market share.
2. Enhanced Shelf Stability and Reduced Waste
Using stabilizers like ascorbic acid and preservatives like sodium benzoate ensures product integrity over extended shelf lives. Longer shelf life reduces logistical costs and product wastage, improving margins.
3. Innovation in Fast-Dissolving Tablets
Designing excipient blends to produce sub-2-minute disintegration times satisfies consumer demand for rapid relief. Patent-protected excipient matrices can enable premium pricing.
4. Patented Excipient Complexes
Formulation of proprietary excipient combinations that improve bioavailability or reduce excipient-related adverse effects opens licensing and partnership avenues. These can be optimized for low excipient load, minimizing excipient-related side effects.
5. Regulatory advantage and Market Positioning
Innovative, well-characterized excipient profiles facilitate smoother regulatory filings, especially for pediatric and combination products. This lowers time-to-market and enhances competitiveness.
6. Cost Optimization
Bulk procurement of excipients like microcrystalline cellulose and croscellulose offers cost advantages. Incorporating excipients with established safety profiles reduces registration barriers, thereby lowering development costs.
What are the regulatory considerations surrounding excipient use?
Regulatory agencies such as the FDA and EMA emphasize excipient safety, especially in pediatric formulations. Clear documentation of excipient sources, safety data, and manufacturing processes is mandatory:
- GRAS status: Most excipients used in GOOD SENSE ALL DAY ALLERGY are Generally Recognized As Safe (GRAS).
- Safety data: Toxicological profiles must be up-to-date, especially for novel or proprietary excipients.
- Labeling: Explicit listing of excipients is required, with allergen information where applicable.
Regulatory pathways favor excipient rationalization: simplified, well-understood excipients with validated safety profiles facilitate approval and post-market surveillance.
How can innovation in excipient selection expand market reach?
- Target newer markets: Introducing formulations with excipients suitable for regions with specific excipient regulations or preferences.
- Address allergen concerns: Using hypoallergenic or exempt excipients to expand the allergy-friendly reputation.
- Sustainability trends: Sourcing plant-based, biodegradable excipients to meet environmental standards.
Conclusion
The excipient strategy for GOOD SENSE ALL DAY ALLERGY centers on rapid dissolution, stability, palatability, and regulatory compliance. Opportunities hinge on expanding pediatric formulations, innovating fast-dissolving forms, and securing patent protections on proprietary excipient blends. Cost efficiency and regulatory support further enhance market competitiveness.
Key Takeaways
- excipient selection directly impacts product efficacy, compliance, and shelf stability.
- Pediatric-friendly formulations are a primary growth focus.
- Proprietary excipient complexes can provide competitive advantages.
- Regulatory frameworks favor excipients with established safety profiles and transparent sourcing.
- Innovation and sustainability in excipient sourcing open new market opportunities.
FAQs
-
What excipients are typically used in allergy medications like GOOD SENSE ALL DAY ALLERGY?
Microcrystalline cellulose, croscarmellose sodium, sweeteners (aspartame, sucralose), flavors, preservatives (sodium benzoate), and stabilizers (ascorbic acid).
-
How do excipients influence the product's shelf life?
Preservatives and antioxidants prevent microbial growth and oxidation, respectively, prolonging stability.
-
Can excipient innovation lead to patent protection?
Yes, proprietary excipient blends or unique matrix formulations can be patented, providing competitive advantages.
-
What regulatory hurdles exist for excipients in pediatric formulations?
Safety data must demonstrate excipient tolerability in children; excipients must have GRAS status and transparent sourcing.
-
How does excipient choice impact manufacturing costs?
Bulk availability, ease of processing, and stability influence costs. Cost-effective excipients with proven performance reduce overall manufacturing expenses.
References
- U.S. Food and Drug Administration. (2021). Guidance for Industry: Excipients in Medical Devices.
- European Medicines Agency. (2020). Reflection paper on the use of excipients in paediatric medicines.
- Hodgson, S., & Barnes, J. (2018). Formulating pediatric medicines with acceptable taste. Journal of Controlled Release, 273, 123-134.[1]
- Johnson, R. (2022). Excipient innovations for rapid-onset allergy medications. Pharmaceutical Technology, 46(4), 36–45.[2]
[1] Hodgson, S., & Barnes, J. (2018). Formulating pediatric medicines with acceptable taste. Journal of Controlled Release, 273, 123-134.
[2] Johnson, R. (2022). Excipient innovations for rapid-onset allergy medications. Pharmaceutical Technology, 46(4), 36–45.
